Toro Neurovascular

Toro Neurovascular is an emerging player in the neurovascular intervention space, specifically targeting the large and growing ischemic stroke market. The company's core innovation is its MicroFlex™ technology, a catheter design that aims to provide superior flexibility and trackability to allow physicians to achieve higher intracranial positioning, which is clinically linked to better procedural outcomes. Founded in 2015 by experienced medical device entrepreneurs, the company appears to be in a late-stage development or early commercial phase, leveraging a leadership team with deep industry experience from companies like Penumbra, Medtronic, and Boston Scientific. Toro's strategy centers on addressing a key technical challenge in stroke thrombectomy—reliable and rapid access—to save critical time and brain function.

MicroFlex™ Technology: A catheter platform using specialized reinforcement wires designed for enhanced flexibility and trackability to achieve higher, more stable intracranial positioning for neurovascular interventions.

Toro competes in the neurovascular access segment against major players like Medtronic, Stryker, Johnson & Johnson, and Penumbra, all of which offer guide catheters and sheaths. Its differentiation is based on the specific flexibility and positioning advantages of its MicroFlex™ technology, aiming to compete on performance rather than price in a crowded field.